Scinai Immunotherapeutics (SCNI) Share-based Compensation (2018 - 2026)
Scinai Immunotherapeutics' Share-based Compensation was $58,000 in Q2 2026, down 17.1% from the prior quarter.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Share-based Compensation (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Scinai Immunotherapeutics' Share-based Compensation was $477,000 through Jun 30, 2026; for FY2025, it was $303,000, down 55.6% from FY2024.
- Share-based Compensation has now declined for five consecutive years, with a five-year compound annual growth rate of -49.8% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $682,000 in FY2024 (-40.1%), $1.14 million in FY2023 (-28.9%), $1.6 million in FY2022 (-41.9%) and $2.76 million in FY2021 (-70.9%).
- The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q1 2019.
- The best year-over-year quarter for Share-based Compensation over five years was Q4 2023 (growth of 13.8%); the worst was Q3 2022 (a decline of 86.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Scinai Immunotherapeutics | 157,066.38 | -8.11 Mn | -1.25 Mn | 58,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58,000.00 |
| Mar 31, 2026 | 70,000.00 |
| Dec 31, 2024 | 204,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 191,000.00 |
| Dec 31, 2023 | 453,000.00 |
| Sep 30, 2023 | 234,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 252,000.00 |
| Dec 31, 2022 | 398,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Jun 30, 2022 | 464,489.38 |
| Mar 31, 2022 | 485,000.00 |
| Dec 31, 2021 | 743,337.52 |
| Sep 30, 2021 | 781,632.15 |
| Jun 30, 2021 | 788,732.05 |
| Mar 31, 2021 | 437,000.00 |
| Dec 31, 2020 | 402,590.85 |
| Sep 30, 2020 | 1.35 Mn |
API Access
Scinai Immunotherapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SCNI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SCNI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SCNI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();